Bartneck J, Hartmann A, Stein L, Arnold-Schild D, Klein M, Stassen M
Front Immunol. 2023; 14:1267866.
PMID: 37849753
PMC: 10577317.
DOI: 10.3389/fimmu.2023.1267866.
Co-Rives I, Chen A, Moore A
Vaccines (Basel). 2023; 11(2).
PMID: 36851328
PMC: 9962282.
DOI: 10.3390/vaccines11020450.
Trimzi M, Ham Y
Pharmaceutics. 2021; 13(11).
PMID: 34834185
PMC: 8620904.
DOI: 10.3390/pharmaceutics13111770.
Meneveau M, Petroni G, Salerno E, Lynch K, Smolkin M, Woodson E
J Immunother Cancer. 2021; 9(5).
PMID: 34035112
PMC: 8154977.
DOI: 10.1136/jitc-2020-002214.
Alving C
Mil Med. 2020; 186(3-4):72-77.
PMID: 33313776
PMC: 7909454.
DOI: 10.1093/milmed/usaa468.
Transcutaneous Administration of Dengue Vaccines.
Andreata-Santos R, Alves R, Pereira S, Pereira L, de Freitas C, Pereira S
Viruses. 2020; 12(5).
PMID: 32384822
PMC: 7290698.
DOI: 10.3390/v12050514.
CCR10 expression is required for the adjuvant activity of the mucosal chemokine CCL28 when delivered in the context of an HIV-1 Env DNA vaccine.
Gary E, Kathuria N, Makurumidze G, Curatola A, Ramamurthi A, Bernui M
Vaccine. 2020; 38(11):2626-2635.
PMID: 32057572
PMC: 10681704.
DOI: 10.1016/j.vaccine.2020.01.023.
Protection against neonatal enteric colibacillosis employing E. Coli-derived outer membrane vesicles in formulation and without vitamin D3.
Beikzadeh B, Nikbakht Brujeni G
BMC Res Notes. 2018; 11(1):302.
PMID: 29769118
PMC: 5956550.
DOI: 10.1186/s13104-018-3442-2.
Multigenic DNA vaccine induces protective cross-reactive T cell responses against heterologous influenza virus in nonhuman primates.
Koday M, Leonard J, Munson P, Forero A, Koday M, Bratt D
PLoS One. 2017; 12(12):e0189780.
PMID: 29267331
PMC: 5739435.
DOI: 10.1371/journal.pone.0189780.
Intradermal immunisation using the TLR3-ligand Poly (I:C) as adjuvant induces mucosal antibody responses and protects against genital HSV-2 infection.
Bardel E, Doucet-Ladeveze R, Mathieu C, Harandi A, Dubois B, Kaiserlian D
NPJ Vaccines. 2017; 1:16010.
PMID: 29263853
PMC: 5707913.
DOI: 10.1038/npjvaccines.2016.10.
Topical CpG Oligodeoxynucleotide Adjuvant Enhances the Adaptive Immune Response against Influenza A Infections.
Cheng W, Plumb A, Lai J, Abraham N, Dutz J
Front Immunol. 2016; 7:284.
PMID: 27524984
PMC: 4965457.
DOI: 10.3389/fimmu.2016.00284.
Hib Vaccines: Past, Present, and Future Perspectives.
Zarei A, Almehdar H, Redwan E
J Immunol Res. 2016; 2016:7203587.
PMID: 26904695
PMC: 4745871.
DOI: 10.1155/2016/7203587.
Induction of mucosal immunity through systemic immunization: Phantom or reality?.
Su F, Patel G, Hu S, Chen W
Hum Vaccin Immunother. 2016; 12(4):1070-9.
PMID: 26752023
PMC: 4962944.
DOI: 10.1080/21645515.2015.1114195.
The catalytic A1 domains of cholera toxin and heat-labile enterotoxin are potent DNA adjuvants that evoke mixed Th1/Th17 cellular immune responses.
Bagley K, Xu R, Ota-Setlik A, Egan M, Schwartz J, Fouts T
Hum Vaccin Immunother. 2015; 11(9):2228-40.
PMID: 26042527
PMC: 4635876.
DOI: 10.1080/21645515.2015.1026498.
Novel antigen delivery technologies: a review.
Jain D, Jain V, Singh R
Drug Deliv Transl Res. 2015; 1(2):103-12.
PMID: 25788109
DOI: 10.1007/s13346-011-0014-6.
Tailored immunity by skin antigen-presenting cells.
Levin C, Perrin H, Combadiere B
Hum Vaccin Immunother. 2014; 11(1):27-36.
PMID: 25483512
PMC: 4514408.
DOI: 10.4161/hv.34299.
Transcutaneous antigen delivery system.
Lee M, Shin M, Yang V
BMB Rep. 2013; 46(1):17-24.
PMID: 23351379
PMC: 4133827.
DOI: 10.5483/bmbrep.2013.46.1.001.
New directions in immunotherapy.
Cox L, Compalati E, Kundig T, Larche M
Curr Allergy Asthma Rep. 2013; 13(2):178-95.
PMID: 23315329
DOI: 10.1007/s11882-012-0335-7.
Generation of antigen-specific immunity following systemic immunization with DNA vaccine encoding CCL25 chemokine immunoadjuvant.
Kathuria N, Kraynyak K, Carnathan D, Betts M, Weiner D, Kutzler M
Hum Vaccin Immunother. 2012; 8(11):1607-19.
PMID: 23151454
PMC: 3601135.
DOI: 10.4161/hv.22574.
Intact skin and not stripped skin is crucial for the safety and efficacy of peanut epicutaneous immunotherapy (EPIT) in mice.
Mondoulet L, Dioszeghy V, Puteaux E, Ligouis M, Dhelft V, Letourneur F
Clin Transl Allergy. 2012; 2(1):22.
PMID: 23140259
PMC: 3542018.
DOI: 10.1186/2045-7022-2-22.